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Docosahexaenoic Acid Alleviates Atopic Dermatitis
by Generating Tregs and IL-10/TGF-b-Modified
Macrophages via a TGF-b-Dependent Mechanism
Sang-Chul Han1, Dong-Hwan Koo2, Na-Jin Kang2, Weon-Jong Yoon3, Gyeoung-Jin Kang4,
Hee-Kyoung Kang1,2 and Eun-Sook Yoo1,2
Regulatory T cells (Tregs) have key roles in the immune response by suppressing the differentiation and
proliferation of various immune cells. The beneficial effects of docosahexaenoic acid (DHA) have been described
for many diseases; however, the mechanism by which it modulates the immune system is poorly understood.
Therefore, the aim of this study was to examine whether DHA suppresses allergic reactions and upregulates the
generation of CD4þFoxp3þ T cells. We also examined the effects of transfusing interleukin-10/transforming
growth factor-b (TGF-b)-modified macrophages (M2 macrophages) treated with DHA into a mouse model of
atopic dermatitis. Here, we show that administration of DHA upregulates the generation of TGF-b-dependent
CD4þ forkhead box protein 3 (Foxp3þ ) Tregs. DHA induced T-cell hypo-responsiveness and downregulated
cytokines associated with T helper (Th)-1, Th2, and Th17 cells. The differentiation of Foxp3þ Tregs into CD4þ
T cells was directly mediated by DHA-M2 macrophages, which deactivated effector macrophages and inhibited
CD4þ T-cell proliferation. DHA showed therapeutic effects in mice with experimental atopic dermatitis. These
results show that DHA enhances the function of M2 macrophages and that the generation of Tregs effectively
protects mice against an inflammatory immune disorder. Thus, DHA may be a useful therapeutic strategy for
treating chronic inflammatory diseases.
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INTRODUCTION
Atopic dermatitis (AD) is a chronic inflammatory skin disease
associated with cutaneous hyperreactivity, including edema
and itching, which affects B10–20% of children and 1–3%
of adults worldwide (Leung et al., 2004). This systemic disorder
is characterized by T-cell hyper-proliferation, skin barrier
dysfunction, severe skin dehydration, and mutations in the
filaggrin gene, which has a vital role in modulating epidermal
homeostasis. The skin lesions in AD patients are characterized
by the proliferation and infiltration of inflammatory cells, such
as mast cells, basophils, eosinophils, and T cells (Wahlgren,
1999; Li et al., 2010; Jakasa et al., 2011).
Regulatory T cells (Tregs) have a key role in immune
responses, including type 2 helper T cell (Th2)-mediated
diseases such as AD, inflammatory bowel disease, and
asthma. Tregs maintain peripheral immune homeostasis and
tolerance to allergens and protect against or attenuate the
differentiation, proliferation, and function of immune cells
such as CD4þ and CD8þ T cells through a process that is
dependent on cell-to-cell contact, transforming growth factor-b
(TGF-b), or interleukin-10 (IL-10; Shevach, 2002; Tiemessen
et al., 2006; Ziegler, 2006). The depletion of Tregs can
exacerbate antigen-induced Th2 cell-mediated inflammation
(Saito et al., 2008). Tregs express high levels of CD25, a well-
known Treg marker, on the cell surface. They also express
forkhead box protein 3 (Foxp3), which is a key regulator of
Treg development and differentiation. CD4þFoxp3þT cells
suppress the activation or proliferation of helper T cells,
including Th1, Th2, and Th17 cells (Shevach et al., 2006;
Zheng and Rudensky, 2007).
In chronic AD lesions, macrophage accumulation correlates
closely with the degree of skin injury and immune dysfunc-
tion. Macrophages have a key role in immune responses. They
assume a defensive role by phagocytosing parasites and
microbes and are essential for the antigen-induced activation
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and proliferation of T and B cells (Elhelu, 1983; Dokmeci and
Herrick, 2008). Macrophages can be classified into two major
functional subsets: (1) Commonly activated macrophages (M1
macrophages), which after stimulation by lipopolysaccharides
(LPS) or interferon-gamma (IFN-g), show characteristic anti-
microbial and cytotoxic properties; and (2) alternatively
activated macrophages (IL-10/TGF-b-modified macrophages
(M2 macrophages)), which are defined by their anti-
inflammatory and regulatory properties. The latter are further
subdivided into M2a (induced by IL-4 or IL-13), M2b (induced
by IL-1 or LPS), and M2c (induced by IL-10, TGF-b)
macrophages (Martinez et al., 2008; Tjiu et al., 2009).
Previous studies examined the anti-allergic effects of fish oil.
Fish oil, which contains various omega-3 polyunsaturated fatty
acids (n-3 PUFAs), can reduce sensitization to allergens,
alleviate the severity of AD, eczema, and asthma, and reduce
the levels of IL-1, IL-4, and IL-13, and IFN-g in serum (Storey
et al., 2005; Kremmyda et al., 2011). The n-3 PUFAs showed
protective effects in animal models of Alzheimer’s and
Parkinson’s disease and more recently in a model of spinal
cord and traumatic brain injury (Bousquet et al., 2008; Bailes
and Mills, 2010; Lopez-Vales et al., 2010). The beneficial
effects of docosahexaenoic acid (DHA) have been described
for many diseases, but the mechanism by which it modulates
immune responses and allergic reactions mediated by
macrophages and CD4þT cells is poorly understood.
Therefore, the aim of this study was to examine whether
DHA suppresses allergic reactions and upregulates the
generation of CD4þFoxp3þT cells. We also examined the
effects of transfusing IL-10/TGF-b/DHA-modified macrophages
(DHA-M2 macrophages) into a mouse model of AD.
RESULTS
DHA suppresses the development of experimental AD
To induce experimental AD, mice were sensitized by applying
1% 2, 4-Dinitrochlorobenzene (DNCB) to the abdomen. They
were then resensitized by applying 0.3% DNCB to the ears on
every other day for up to 41 days. Starting on day 12, the mice
received a daily dose of DHA (100 mg kg1) via the drinking
water (Figure 1a). IgE is an important therapeutic target for AD,
as it is the major activator of mast cells, which release
histamine (Levin et al., 2006). Therefore, we measured the
levels of serum IgE and histamine in mice with dermatitis. The
DHA-treated group showed significantly reduced levels of IgE
and histamine (both Po0.01) compared with the induction-
only group (mice exposed to DNCB but not fed DHA;
Figure 1b). The skin lesions associated with AD are character-
ized by an inflammatory cell infiltrate (de Vries et al., 1997).
Therefore, we next tested whether DHA reduced the level of
inflammatory cell infiltration in the ears of mice with
experimental AD. We also examined cutaneous edema as a
measure of AD progression. We found that the ear thickness in
DHA-fed mice was reduced at days 33 and 42 (both Po0.01)
compared with that observed in the induction-only mice
(Figure 1c and d). Thymic stromal lymphopoietin, which is
produced by epidermal keratinocytes, dermal fibroblasts, and
mast cells, induces both the maturation of antigen presenting
cells and allergic inflammatory reactions (Soumelis et al.,
2002; Bogiatzi et al., 2007). Therefore, we next examined the
effect of DHA on the infiltration of inflammatory cells and the
expression of thymic stromal lymphopoietin by hematoxylin
and eosin staining and immunohistochemical staining of ear
tissue sections, and by western blotting. Epidermal thickness,
the degree of inflammatory cell infiltration, and the expression
of thymic stromal lymphopoietin were significantly lower
in the DHA-treated group than in the induction-only group
(Figure 1e and f).
CD4þFoxp3þ T cells are enriched at the sites of inflammation
and are associated with AD suppression
The lymph nodes (LNs) have an important role in cell-
mediated immunity by regulating the activity of mature
T and B cells (Debes et al., 2004). Therefore, we examined
the morphologic changes in the LN of AD mice. The LNs
from mice in the induction-only group were very swollen,
whereas those from DHA mice were smaller and weighed
less (Figure 2a). We also examined whether DHA suppresses
the function of mature CD4þT cells in the experimental
AD model. We measured the relative expression of IFN-g
(Th1), IL-4, IL-5 and IL-31 (Th2), and IL-17 (Th17) transcripts
by real-time PCR. Compared with the induction group, DHA-
fed mice showed reduced IFN-g (Po0.05), IL-31 (Po0.01), IL-
17A (Po0.001), IL-4, and IL-5 mRNA levels (Figure 2b).
Because CD4þFoxp3þTregs suppress the activity and gen-
eration of pathogenic effector cells at the site of inflammation
via direct cell-to-cell contact or by secreting TGF-b and IL-10
(Huehn and Hamann, 2005; Vignali et al., 2008), we
examined the population of Foxp3þTregs at the
inflammatory sites (the LN in AD mice) by FACS analysis
and immunofluorescence staining. FACS analysis showed a
significant increase in the number of Foxp3þT cells in DHA
mice compared with Cont mice (30.8% vs. 19.7%,
respectively; Figure 2c). This was confirmed by IF analysis of
LN section (Figure 2d).
DHA administration induces the differentiation of CD4þFoxp3þ
Tregs from CD4þ T cells in a TGF-b-dependent manner
Tregs have a key role in immune processes by preventing or
suppressing the differentiation, proliferation, and function
of CD4þT cells (Sakaguchi et al., 2009). Therefore, we
examined whether DHA affects the expression of factors
related to Treg cell differentiation during T-cell activation.
DHA was fed to normal BALB/c mice for 30 days, and the
mice were killed on Day 31 (Figure 3a). Compared with
the control group (non-DHA-fed mice), DHA suppressed the
expression of IFN-g, IL-4, IL-5 (all Po0.05), IL-31 (Po0.001),
IL-13, and IL-17A mRNA and increased the expression of
TGF-b and cytotoxic T-lymphocyte–associated-4 (CTLA-4;
both Po0.05) mRNA (Figure 3b). In addition, the CD4þ
T cells of the DHA group showed increased expression of
Foxp3 and TGF-b in the presence of TGF-b (Supplementary
Figure S1a online). Although DHA also increased the CD4þ
Foxp3þ population in the presence of exogenous TGF-b,
which induces the generation of Tregs in vitro (Figure 3c,
Supplementary Figure S1b and c online), we found no differ-
ence in the size of the CD4þCD25þ population between the
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two groups (Figure 3d). Compared with the control group,
CD4þCD25T cells (responder) from the DHA group were
slightly more sensitive to suppression by CD4þCD25þTregs
(suppressors; Figure 3f), although the inhibitory effects of Treg
isolated from DHA-fed mice on normal CD4þT cell prolifera-
tion were no different from that of Tregs isolated from control
mice (Figure 3e). However, CD4þCD25T cells from DHA-
fed mice were significantly more susceptible to suppression by
CD4þCD25þTregs in the presence of exogenous TGF-b
(Figure 3f). These observations indicate that DHA induced
the generation of CD4þFoxp3þTregs from the CD4þCD25
cell pool and inhibited the proliferation of CD4þT cells via a
TGF-b-dependent mechanism.
DHA strongly upregulates the function of M2 macrophages,
which induce the generation of CD4þFoxp3þ T cells
We next examined the role of M2 macrophages in the DHA-
induced generation of CD4þFoxp3þ Tregs. CD11bþ macro-
phages were isolated from normal BALB/c mice and
stimulated with LPS, IL-10, TGF-b, or IL-10/TGF-b, and the
expression of inflammatory cytokines was measured. Com-
pared with control mice, DHA inhibited the expression of IL-6
(Po0.001) by LPS-stimulated macrophages; however, treat-
ment with other anti-inflammatory cytokines had no effect in
either group (Figure 4a). In addition, DHA-M2 macrophages
expressed higher levels of IL-10 and TGF-b compared
with M0 (non-stimulation), M1 (LPS stimulation), IL-10-,
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Figure 1. Docosahexaenoic acid (DHA) suppresses experimental atopic dermatitis (AD). (a) Mice were challenged with 2, 4-Dinitrochlorobenzene. From day 12,
mice were fed a daily dose of docosahexaenoic acid (100 mg kg1) in the drinking water. (b) The IgE and histamine levels in serum were measured by ELISA.
(c) Macroscopic views of the ears and (d) ear thickness measured on days 0, 11, 33, and 42. (e) Paraffin-embeded sections of ear tissue stained with hematoxylin
and eosin and toluidine blue. (f; upper panel) Immunohistochemical (IHC) staining was performed with a anti-thymic stromal lymphopoietin (TSLP) antibody and
the HRP/DAB detection IHC kit. (f; lower panel) TSLP levels were measured in ear tissues by western blotting. (n¼ 10 mice per group). Scale bar¼ 0.1 mm. Values
represent the mean±SD. **Po0.01; ***Po0.001.
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TGF-b-stimulated macrophages, or control-M2 macrophages
from both the groups (Figure 4a). We also compared the
inhibitory effects of M2 macrophages between the control and
DHA-treated groups on the expression of pro-inflammatory
cytokines by M1 macrophages. Compared with the co-culture
of M1 macrophages with control-M2 macrophages, co-culture
of M1 macrophages with DHA-M2 macrophages for 24 hours
led to a significant reduction in the expression of IL-6 (Po0.01
DHA vs. Po0.05 control), TNF-a (both Po0.05), and IL-1b
(Po0.01 DHA vs. Po0.05 control; Figure 4b). We then tested
whether DHA treatment of M2 macrophages had the potential
to induce Foxp3þTregs. M0, M1, and M2 macrophages were
isolated from each group and co-cultured with CD4þ T cells
for 7 days. The CD4þFoxp3þ Tregs populations were then
analyzed by flow cytometric analysis. When compared with
control-M2 macrophages, DHA-M2 macrophages induced the
preferential differentiation of CD4þ T cells into CD4þ
Foxp3þ T cells (14.4% DHA vs. 8.0% Cont; 44.3% DHA
vs.’ 39.4% Cont, Figure 4c and Supplementary Figure S2a
online). By contrast, neither M0 nor M1 macrophages induced
the transformation of CD4þ T cells into Tregs (Figure 4c). In
addition, transwell and neutralizing antibodies studies showed
that DHA-M2 macrophage–mediated Treg induction required
cell-to-cell contact and TGF-b (Figure 4d and Supplemen-
tary Figure S2b online). The proliferation of CD4þ T cells
co-cultured with DHA-M2 macrophages was significantly
reduced, as shown by the higher ratio (macrophages: CD4þ
T cells) in the DHA-M2 macrophages group compared with
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Figure 2. CD4þFoxp3þ T cells are enriched at the sites of inflammation. (a) The lymph nodes (LNs) were photographed and measured to record morphologic
changes. (b) Cytokines and (c) forkhead box protein 3 (Foxp3) levels expressed by CD4þ T cells isolated from lymphocytes were analyzed by real-time PCR and
FACS. (d) Sections of LN were stained with a rabbit anti-Foxp3 antibody and then incubated with DyLight488-conjugated donkey anti-rabbit IgG. Tissue sections
were analyzed using confocal microscopy; Foxp3 is green and the nuclei are blue. (n¼ 10 mice per group). Scale bar¼ 0.1 mm. Values represent the mean±SD.
*Po0.05, **Po0.01, and ***Po0.001 compared with mice in the induction group.
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that in the M0, M1, and Cont-M2 macrophages groups (this
was attributable to the increased Treg population in the DHA-
M2 macrophages group). By contrast, M1 macrophages
induced significantly greater T-cell proliferation compared
with M0 or M2 macrophages in all the groups (Figure 4e
and Supplementary Figure S2c online). Collectively, these
results suggest that DHA strongly upregulates the function of
M2 macrophages, which have the capacity to convert Foxp3
T cells into Foxp3þ Tregs through cell-to-cell contact, and the
secretion of TGF-b.
Transfusion of DHA-M2 macrophages protects against
experimental AD
To induce experimental AD, mice were sensitized by applying
1% DNCB to the abdomen and then resensitized by applying
0.5% DNCB to their ears on every other day for up to 26 days.
Starting on days 12 and 19, mice received a single injection of
CM-DiI-labeled DHA-M2 macrophages into the tail-vein. All
mice were killed on day 27 (Figure 5a). Compared with the
induction-only group, DHA-M2 macrophage–injected mice
showed a significant reduction in ear thickness at days 18 and
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chambers for 7 days. (f) CD4þT cells labeled with carboxyfluorescein succinimidyl ester were co-cultured with macrophages and stimulated by anti-CD3/-CD28
for 72 hours. Values represent the mean±SD. Data are representative of three independent experiments. *Po0.05, **Po0.01, and ***Po0.001.
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26 (Po0.01; Figure 5b and d) and reduced IgE levels (Po0.01;
Figure 5e). We also found that the LNs from DHA-M2
macrophage–injected mice were smaller compared with those
from mice in the induction-only group (Figure 5c). In addition,
transfusion of DHA-M2 macrophages suppressed the expres-
sion of IFN-g, IL-4 (both Po0.05), IL-13, and IL-17A mRNA
and increased that of TGF-b, IL-10, and Foxp3 (Po0.05)
compared with that observed in the induction-only group
(Figure 5f). Next, we examined the number of transfused
DHA-M2 macrophages present at the sites of inflammation in
AD mice. Many fluorescently labeled cells were detected in
the ear, LN, and spleen, although most were present in the LN
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Figure 5. Transfusion of docosahexaenoic acid (DHA)-M2 macrophages protects against experimental atopic dermatitis (AD). (a) Mice were challenged with 2,
4-Dinitrochlorobenzene. On days 12 and 19, CM-DiI-labeled docosahexaenoic acid (DHA)-IL-10/TGF-b-modified macrophages (M2) macrophages were injected
into atopic dermatitis AD mice. (b, c) Macroscopic views of the ears, lymph nodes (LNs), and (d) ear thickness. (e) IgE levels in the serum were measured by ELISA.
(f) Real-time PCR was used to measure the expression of mRNA for cytokines and transcription factors in CD4þ T cells. (g) CM-DiI-labeled macrophages in the ear,
spleen (SP), and LN were examined by confocal microscopy. (h) The expression of Foxp3 was measured in LN and SP tissues by immunohistochemical staining
and western blotting. Scale bar ¼ 0.1 mm. Values represent the mean±SD. *Po0.05 and **Po0.01.
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(Figure 5g). We also measured the population of Foxp3þTregs
in the LN and spleen by immunohistochemical and western
blot analyses. DHA-M2 macrophage–injected mice showed a
significant increase in the number of Foxp3þT cells compared
with the Cont and Hydrocort groups (Figure 5h). These results
suggest that DHA-M2 macrophages suppress inflammation by
inducing the generation of Foxp3þ Tregs.
DISCUSSION
A recent study reports that patients suffering from atopic eczema
aged 18–40 years received a high dose of DHA (5.4 g/daily) for
8 weeks, and DHA resulted in a clinical improvement of atopic
eczema (Koch et al., 2008). Here, we examined how the potent
anti-inflammatory properties of DHA affect the progression of
experimental AD. DHA also increased the number of adaptive
Tregs in healthy mice and in AD. The protective effect
of DHA was associated with the upregulated levels of
CD4þFoxp3þTregs at the sites of inflammation. Tregs control
immune homeostasis in AD and suppress immune responses by
interacting with effector T cells or antigen presenting cells
(Vignali et al., 2008). In experimental AD models, the lack of
Tregs leads to elevated serum IgE levels and production of Th2
cytokines (Lin et al., 2005). When comparing Treg cell
populations in the peripheral blood of AD patients with those
in the blood of healthy donors, several groups reported
increased numbers of Tregs in AD patients (Ou et al., 2004).
However, Tregs in AD patients do not protect against or
attenuate the differentiation, proliferation, and function of
immune cells such as CD4þ and CD8þ T cells (Hijnen
et al., 2009; Ito et al., 2009). The enriched CD4þ
Foxp3þTreg population induced by DHA may suppress pro-
inflammatory effector T cells (Th1/2/17 cells) at the sites of
inflammation, resulting in a protective effect in AD models.
DHA strongly upregulates the function of M2 macrophages,
which induce the generation of CD4þFoxp3þ Tregs. The
enrichment of CD4þFoxp3þ Tregs at the sites of inflamma-
tion is associated with the upregulation of TGF-b, which inhibits
the progression of several immune disorders. The
immunomodulatory actions of DHA are achieved via the
increased expression of immunosuppressive cytokines, such as
TGF-b, and by suppressing the secretion of pro-inflammatory
cytokines (IFN-g, IL-4, IL-5, IL-13, IL-31, IL-17, and IL-6) by
CD4þT cells and macrophages. DHA did not increase the
number of CD4þCD25þ Tregs; however, it did increase
cytotoxic T-lymphocyte–associated-4 expression by
CD4þCD25-T cells by 42-fold. DHA may not generate
adaptive Tregs directly; rather, it may promote the expression
of TGF-b, which then induces T cells to differentiate into Tregs
to inhibit disease progression. The DHA-M2 macrophages
regulate pro- and anti-inflammatory cytokines, and there are a
number of potential mechanisms. Currently, we are trying to
identify and amplify the role of the pattern recognition receptors
(Toll-like receptors and B7-H4). Among the various receptors,
B7-H4 is the inhibitory molecule of the B7 family and M2
macrophages were found to express high levels of B7-H4,
whereas M1 or IL-4/13-modified macrophages did not. A recent
study reports two novel observations about B7-H4 and M2
macrophages; first, M2 macrophages can be distinguished from
M1 or IL-4/13-modified macrophages by their high level
expression of B7-H4. Next, B7-H4 on M2 macrophages not
only suppresses CD4þT-cell proliferation but also can induce
Tregs (Cao et al., 2010). Macrophages can act as antigen
presenting cells, which present pathogen-derived antigens (from
viruses or bacteria) directly to T cells and interact with both T
and B cells to maintain anti-inflammatory immune responses
via various mechanisms (Huang et al., 2000). CD11bþ M2
macrophages protect the kidneys from structural and functional
injury by secreting high levels of TGF-b (Cao et al., 2010). TGF-
b is a powerful anti-inflammatory cytokine that induces the
differentiation of Foxp3þ Tregs from CD4þT cells (Fu et al.,
2004). M2, but not LPS-modified (M1), macrophages induce the
differentiation of Treg cells (Savage et al., 2008). Therefore, we
postulated that DHA generates stronger function of M2
macrophages, which express higher levels of TGF-b. Indeed,
we showed that treatment of M2 macrophages with DHA drives
CD4þCD25-T cells to differentiate into CD4þFoxp3þT cells;
however, transwell assays showed that inhibition of cell-to-cell
contact strongly suppressed the generation of Tregs. Previous
studies in experimental disease models showed that the
adoptive transfer of M1 macrophages exacerbated inflamma-
tion and induced marked renal injury (Ikezumi et al., 2003).
Here, in vitro co-culture of DHA-M2 macrophages with M1
macrophages showed that DHA-M2 macrophages deactivated
pro-inflammatory macrophages (M1 phenotype) more potently
than did normal M2 macrophages. Also, the results so far show
that the transfusion of untreated-M2 macrophages may protect
mice against experimental AD but not nearly as much as DHA-
M2 macrophages. To our knowledge, it is previously
unreported that deactivation of inflammatory macrophages by
DHA-M2 macrophages may explain why DHA-M2
macrophages protect against AD.
We also examined various n-3 PUFAs) to detect which had
the most potent immunoregulatory effect (data not shown).
Recently, we developed an in vitro screening system to identify
immunoregulatory n-3 PUFAs that induce Foxp3 but suppress
pro-inflammatory cytokines. Thus, we compared the difference
between DHA and eicosapentaenoic acid, both n-3 PUFAs that
modulate the immune system. After co-culturing lymphocytes
with each of the n-3 PUFAs for 3 days, we found that DHA
suppressed the expression of IFN-g and IL-4. In addition, we
determined the optimal dosage and treatment duration of DHA
on the basis of the criteria that enhanced Foxp3 expression. In
summary, M2 macrophages recognize and process DHA.
During this process, normal CD11bþM2 macrophages induce
the differentiation of CD4þFoxp3T cells into CD4þFoxp3þ
Tregs in a TGF-b-dependent manner. Finally, the Tregs down-
regulate the pro-inflammatory functions of Th cells, which
leads to the suppression of disease progression.
MATERIALS AND METHODS
Experimental animals
BALB/c mice (7 weeks old) were purchased from Orient Bio (Orient
Bio Inc., Seongnam, Korea) (Orient Bio Inc., Seongnam, Korea)
and maintained under pathogen-free conditions in the animal facility
of Jeju National University. All animal experiments were approved by
the Jeju National University Animal Care and Use Committee.
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Determination of optimal dosage and treatment duration of DHA
To determine the optimal dose of DHA, we tested the expression of
Foxp3 by DHA in the DNCB-induced AD model. AD was induced by
applying DNCB to the mice ear, and DHA was then orally
administered with diverse doses (10, 50, and 100 mg kg 1) in
drinking water for 30 days. A minimum dosage of 50 mg kg 1 of
DHA was required to induce Foxp3 expression, and a dosage of
100 mg kg 1 of DHA showed the most potent effects in DNCB-
induced AD. To find the minimum duration of DHA treatment, DHA
was differentially administrated for 10, 20, or 30 days. Results
indicated that 430 days of DHA treatment was required to induce
Foxp3 expression in DNCB-induced AD.
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